A row has erupted between cardiology experts and GP leaders over prescribing a breakthrough heart drug that could save tens of thousands of lives.
The medicine, called inclisiran, is a twice-a-year jab that slashes levels of so-called ‘bad’ cholesterol by more than 50 per cent after just two weeks. It has been approved for use on the NHS since 2021 for patients with stubbornly high cholesterol levels who have already suffered a heart attack.
NHS England say the drug could